Clinical Study of KD6001 in Advanced Solid Tumours
Clinical trial NCT05230290 · COMPLETED
Trial details
- NCT number
- NCT05230290
- Sponsor
- Shanghai Kanda Biotechnology Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-10
- Primary completion
- 2022-07-20
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.